NCT04163978View on ClinicalTrials.gov

Nitric Oxide Releasing Sinus Irrigation (NOSi) to Treat Recalcitrant Chronic Rhinosinusitis (RCRS)

PHASE2CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

October 27, 2019

Primary Completion Date

May 3, 2022

Study Completion Date

May 3, 2022

Conditions
Chronic Sinusitis
Interventions
DRUG

Nitric Oxide

in situ 240mL nitric oxide releasing sinus irrigation solution

DRUG

Budesonide

Saline based sinus irrigation 1mg Budesinide solution

Trial Locations (1)

V6Z 1Y6

St. Paul's Hospital, Vancouver

All Listed Sponsors
lead

Sanotize Research and Development corp.

INDUSTRY

NCT04163978 - Nitric Oxide Releasing Sinus Irrigation (NOSi) to Treat Recalcitrant Chronic Rhinosinusitis (RCRS) | Biotech Hunter | Biotech Hunter